Add BrightSurf on Google Email

Waistline matters in kidney disease

Obesity, as measured by body mass index and abdominal fat content, is associated with an increased risk of heart disease and progression of kidney disease in patients with chronic kidney disease. Lower physical fitness levels are also linked to a higher cardiovascular risk.

SourceNational Kidney Foundation·JournalAmerican Journal of Kidney Diseases·DateAug 13, 2020

Scientists sound the alarm: Lockdowns may escalate the obesity epidemic

A trio of Danish researchers warn that lockdowns could lead to an explosion in obesity rates due to increased consumption of high-energy foods and decreased physical activity. The study highlights the need for counter strategies to promote healthy eating habits and physical activity while combatting COVID-19.

Fatty liver disease despite a normal weight

Non-alcoholic fatty liver disease (NAFLD) affects both obese and non-obese individuals, with distinct differences found in male and female patients of varying body mass indexes. Key findings include lower skeletal muscle mass and insulin resistance in non-obese NAFLD patients compared to their obese counterparts.

SourceUniversity of Tsukuba·JournalHepatology Research·DateAug 3, 2020

Mismatched caregiver-infant interactions during feeding could boost babies' risk of later obesity

Infants who are fed in the absence of hunger or beyond fullness may develop skewed perceptions of hunger and fullness, increasing their risk of obesity. Caregiver-infant interactions during feeding can shape infants' self-regulation of energy intake, with feeding responsiveness to cues being linked to obesity.

SourceSociety for Research in Child Development·JournalChild Development Perspectives·DateJul 14, 2020

Study finds weight loss surgery cost disparity

A new study from the University of Georgia finds that bariatric weight loss surgery is more expensive for public insurance patients compared to private insurance. The study analyzed a national dataset and found that Medicare patients paid the highest average cost per surgery, while publicly insured patients paid more overall.

SourceUniversity of Georgia·JournalClinical Obesity·DateJul 13, 2020

Blood vessels can make you fat, and yet fit

Researchers have identified Angiopoietin-2 as a hormone that enables the proper transport of fatty acids into blood vessels, preventing insulin resistance and promoting healthier weight distribution. By targeting this mechanism, scientists hope to develop novel therapeutic strategies for treating obesity-induced metabolic disorders.

SourceInstitute for Basic Science·JournalNature Communications·DateJun 24, 2020

Obesity linked to higher dementia risk

A new study published in the International Journal of Epidemiology found that obesity is associated with a higher risk of dementia, with women facing a 39% increased risk. The study suggests that weight management could play a significant role in reducing this risk.

SourceUniversity College London·JournalInternational Journal of Epidemiology·DateJun 23, 2020

Mouse model identified to study common form of heart failure linked to age-related obesity

Researchers at the University of South Florida Health have identified a mouse model that mimics human heart failure with preserved ejection fraction (HFpEF) syndrome. The study found that mice deficient in a receptor needed to clear chronic inflammation develop obesity and heart failure, offering new potential targets for therapies.

SourceUniversity of South Florida (USF Health)·JournalThe FASEB Journal·DateJun 22, 2020

NAFLD in pregnancy increases risks for mother and baby

Women with non-alcoholic fatty liver disease (NAFLD) in pregnancy face increased risks of maternal and infant health complications. The study found that NAFLD is associated with hypertensive complications, preterm birth, and maternal bleeding after delivery, independent of other metabolic diseases.

SourceElsevier·JournalJournal of Hepatology·DateJun 9, 2020

Chemicals often found in consumer products could lead to obesity and fatty liver diseases

A Baylor University study found that exposure to obesogens, chemical compounds disrupting normal metabolic processes, can lead to increased susceptibility to weight gain across the lifespan. The study highlights the potential effects of chemicals in consumer products on lipid-related diseases, including obesity and fatty liver disease.

SourceBaylor University·JournalToxicology and Applied Pharmacology·DateMay 19, 2020

New insights into links between national income and obesity

Analysis of data from 147 countries found a strong association between rising incomes and increasing obesity rates, with an average increase in obesity rates for every 1% rise in GDP per capita. The study suggests that policy initiatives may be necessary to combat obesity in low- and middle-income countries undergoing income growth.

SourcePLOS·JournalPLOS ONE·DateMay 13, 2020

Cholesterol lowering drugs linked to improved gut bacteria composition in obese people

Research finds that statin drugs may modulate disrupted gut microbiota and inflammation in obesity, with improved Bact2 enterotype composition in treated individuals compared to non-treated counterparts. Statin therapy may also have anti-inflammatory effects via improvement of an aberrant gut microbiota.

Different kinds of white fat are important in disease

Researchers at Joslin Diabetes Center have discovered two subtypes of human white subcutaneous fat cells with distinct patterns of gene expression, which may help control whether cells become mature fat cells. This study highlights the potential of bringing together biology, artificial intelligence, and data analysis to better understa...

SourceJoslin Diabetes Center·JournalNature Communications·DateMay 4, 2020